Latest Breaking News On - Global pharmaceutical development - Page 1 : vimarsana.com

Clinical Data Published at ASCO Support the Potential of VIVUS PANCREAZE® to Stabilize Weight and Improve Gastrointestinal Outputs in Patients with Pancreatic Cancer

Clinical Data Published at ASCO Support the Potential of VIVUS PANCREAZE® to Stabilize Weight and Improve Gastrointestinal Outputs in Patients with Pancreatic Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSantosht vargheseAndrewe hendifarSinai medical centerAmerican society of clinical oncologySamuel oschin cancer centerCedars sinai medical centerAmerican pancreatic associationOncology fellowship programGlobal pharmaceutical developmentData publishedStabilize weightImprove gastrointestinal outputsClinical oncologyAnnual meetingNeuroendocrine oncology

VIVUS Announces Key Management Updates to Support Global

CAMPBELL, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) VIVUS LLC today announced the promotion of Santosh T. Varghese, MD, to President VIVUS Global.

John amosSantosht vargheseSapienza university of romeGlobal pharmaceutical developmentChief medicalChief executive officerAlessandro giacomettiVice presidentGeneral managerGlobal commercial leadSenior marketing directorSapienza universityCautionary note regarding forward lookingPrivate securities litigation reform act

Interview with the CEO and the CFO: Aethlon Medical, Inc (NASDAQ:AEMD)

Interview with the CEO and the CFO: Aethlon Medical, Inc (NASDAQ:AEMD)
twst.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from twst.com Daily Mail and Mail on Sunday newspapers.

Stanford universityUnited statesUniversity of southern californiaJamesb frakesCharlesj fisher jrDefense science research councilUniversity of california at davis medical centerProteinc global product teamGlobal pharmaceutical developmentCardiome pharma corpEli lilly coAethlon medical incCleveland clinic foundationMargaux biologics incCase western reserve universityAethlon medical

Bob Discordia Joins CaaMTech as Chief Scientific Officer

Dr. Discordia brings over 30 years of pharmaceutical industry experience to CaaMTech ISSAQUAH, Wash. - February 17, 2022 - (Newswire.com) CaaMTech, Inc. announced today that the company has appointed Robert (Bob) Discordia, Ph.D., as its Chief Scientific Officer (CSO). Dr..

Bob discordiaDavis wuolleRobert bob discordiaAndrew chadeayneUniversity of massachusetts dartmouthNational institute on drug abuseAvanzarx pharmaceuticalsDevelopment for corbus pharmaceuticalsGlobal pharmaceutical developmentCaamtech incLeibniz institute for natural product researchDesigner drug research unitBristol myers squibbChief scientific officerBristol myersBusiness operations

BioSpace Movers & Shakers, June 4

Biopharma and life sciences organizations strengthen their leadership teams and board with these Movers & Shakers.

Wills eye hospitalUnited statesM karen newell rogersMyers squibbDenise straussMarc semigranDavidc hanleyEric castaldiJen hongMeagher flomMarc massiotNewell rogersRobin knifsendTheodore reissJeff cruikshankEvelo biosciences